Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Megacap 300 Index ETF Vanguard | MGC | Sep 27, 2024 | 205.80 | -0.11 |
Megacap 300 Value Index ETF Vanguard | MGV | Sep 27, 2024 | 127.83 | +0.33 |
MEI Pharma | MEIP | Sep 27, 2024 | 2.90 | 0.00 |
Meihua International Medical Technologies | MHUA | Sep 27, 2024 | 1.04 | +1.96 |
MeiraGTx Holdings | MGTX | Sep 27, 2024 | 4.26 | +1.91 |
Meiwu Technology | WNW | Sep 27, 2024 | 0.87 | -0.42 |
Melar Acquisition I | MACI | Sep 27, 2024 | 9.99 | 0.00 |
Melar Acquisition I | MACIU | Sep 27, 2024 | 10.03 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Sep 27, 2024 | 7.70 | +1.72 |
MercadoLibre | MELI | Sep 27, 2024 | 2 064.71 | -1.69 |
Mercantile Bank | MBWM | Sep 27, 2024 | 42.56 | -0.42 |
Mercer International | MERC | Sep 27, 2024 | 6.63 | +4.41 |
Merchants Bancorp | MBIN | Sep 27, 2024 | 44.52 | +0.32 |
Merchants Bancorp B | MBINO | Sep 27, 2024 | 25.15 | +0.20 |
Merchants Bancorp C Pref | MBINN | Sep 27, 2024 | 23.98 | +0.42 |
Merchants Bancorp Pref D | MBINM | Sep 27, 2024 | 25.96 | -0.54 |
Merck & Co | MRK | Sep 27, 2024 | 113.69 | +0.53 |
Mercurity Fintech | MFH | Sep 27, 2024 | 1.75 | +26.67 |
Mercury General | MCY | Sep 27, 2024 | 63.23 | -1.08 |
Mercury Systems | MRCY | Sep 27, 2024 | 37.50 | +1.43 |
Mereo BioPharma ADR | MREO | Sep 27, 2024 | 4.14 | +0.98 |
Meridian | MRBK | Sep 27, 2024 | 12.61 | -0.47 |
MeridianLink | MLNK | Sep 27, 2024 | 20.99 | -8.42 |
Merit Medical Systems | MMSI | Sep 27, 2024 | 97.68 | +0.13 |
Meritage Homes | MTH | Sep 27, 2024 | 203.74 | +1.53 |
Merrill Lynch & Co. | IPB | Sep 27, 2024 | 26.70 | 0.00 |
Mersana Therapeutics | MRSN | Sep 27, 2024 | 1.85 | 0.00 |
Merus N.V | MRUS | Sep 27, 2024 | 47.74 | +1.17 |
Mesa Air Group | MESA | Sep 27, 2024 | 1.18 | -1.67 |
Mesa Laboratories | MLAB | Sep 27, 2024 | 127.72 | +0.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.